Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00267319
Status:
COMPLETED
Last Update Posted:
2009-12-07
First Post:
2005-12-19
Brief Title:
FOCUS Fatigue Outcome in Copaxone USers
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
Fatigue Outcomes of Copaxone Users in Relapsing-remitting Multiple Sclerosis
Status:
COMPLETED
Status Verified Date:
2009-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study primarily investigates the effect of copaxone on fatigue during treatment compared to baseline in patients with relapsing-remitting multiple sclerosis
Secondary outcome measures aredisability relapse rate quality of life and depression
Secondary outcome measures aredisability relapse rate quality of life and depression
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None